Sofosbuvir is already used to treat hepatitis C and has passed all human use approval tests, so it can be fairly easily deployed if the chikungunya epidemic forecast for the next two years materializes.
from Latest Science News -- ScienceDaily https://ift.tt/2ErWTge
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment